Song Geehyun, Lim Bumjin, Han Kyung-Sik, Song Sang Hoon, Park Hyung Keun, Hong Bumsik
1 Department of Urology, Kangwon National University Hospital , Chuncheon, Kangwon, Korea.
J Endourol. 2015 Apr;29(4):485-9. doi: 10.1089/end.2014.0394. Epub 2014 Oct 23.
To report complications, including three types of fistula, intractable hematuria, and pain, which can develop after polymeric ureteral stent (PUS) or metallic ureteral stent placements and to evaluate the risk factors for these adverse events.
We reviewed seven patients referred to our trauma and reconstructive subdivision for complications that presented after placement of a PUS (two patients), double-layered, coated, self-expandable, mesh metallic stent (three patients), Memokath stent (one patient), or Resonance stent (one patient). We retrospectively reviewed their medical records and accessed the predisposing factors, mechanism of injury, diagnosis, and interventional and surgical management.
The two patients with PUS presented with ureteroarterial fistula (UAF). Among patients with a self-expandable metallic mesh stents, UAF developed UAF in one patient, ureteroenteral fistula (UEF) developed in one patient, and ureterovaginal fistula (UVF) developed in one patient. There were five patients with fistula who had a history of pelvic surgery, radiation therapy, long-term ureteral stent, or high-pressure balloon dilation. Surgical procedures were needed to manage these problems, including nephrectomy in two patients and bypass surgery with ureter ligation in two patients. UAF was seen with massive gross hematuria that necessitated angiography. UEF required small bowel resection. The patient with UVF underwent multiple surgeries for recurrent fistula. Patients with a Memokath or Resonance stent presented with intractable flank pain and hematuria. These persons required a surgical or other procedure to remove the stents.
UAF should be highly suspected in patients with long-term ureteral stents, especially if gross hematuria develops. The placement of a metallic ureteral stent using a high-pressure balloon should be performed cautiously, especially in patients with a history of pelvic surgery or radiation.
报告在置入聚合物输尿管支架(PUS)或金属输尿管支架后可能出现的并发症,包括三种类型的瘘、顽固性血尿和疼痛,并评估这些不良事件的危险因素。
我们回顾了7例因PUS置入后出现并发症(2例)、双层涂层自膨式网状金属支架置入后出现并发症(3例)、Memokath支架置入后出现并发症(1例)或Resonance支架置入后出现并发症(1例)而转诊至我们创伤与重建科室的患者。我们回顾性分析了他们的病历,探讨了易感因素、损伤机制、诊断以及介入和手术治疗方法。
2例PUS患者出现输尿管动脉瘘(UAF)。在自膨式金属网状支架置入患者中,1例出现UAF,1例出现输尿管肠瘘(UEF),1例出现输尿管阴道瘘(UVF)。5例瘘患者有盆腔手术、放疗、长期输尿管支架置入或高压球囊扩张史。需要通过手术来处理这些问题,包括2例行肾切除术,2例行输尿管结扎的旁路手术。UAF伴有大量肉眼血尿,需要进行血管造影。UEF需要行小肠切除术。UVF患者因复发性瘘接受了多次手术。置入Memokath或Resonance支架的患者出现顽固性胁腹痛和血尿。这些患者需要通过手术或其他方法取出支架。
对于长期留置输尿管支架的患者,尤其是出现肉眼血尿时,应高度怀疑UAF。使用高压球囊置入金属输尿管支架时应谨慎操作,尤其是有盆腔手术或放疗史的患者。